Avadel Pharmaceuticals PLC (AVDL) Earnings History & Surprises
NASDAQ:AVDL • IE00BDGMC594
21.64 USD
+0.01 (+0.05%)
At close: Feb 11, 2026
21.65 USD
+0.01 (+0.05%)
After Hours: 2/11/2026, 8:07:16 PM
Past quarterly earnings results for Avadel Pharmaceuticals PLC (AVDL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 9, 2026
PeriodQ4 / 2025
EPS Estimate$0.09
Revenue Estimate80.251M
Last Reported
Release DateNov 4, 2025
PeriodQ3 / 2025
EPS Reported$0.00
EPS Surprise -100.00%
Revenue Surprise 3.23%
Beat Rate
69%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 0.00 | 0.07 | -100.00% | 100.00% | 77.467M | 75.045M | 3.23% | 54.86% |
| Q2 2025 | 0.10 | 0.03 | 258.07% | 171.43% | 68.129M | 62.728M | 8.61% | 64.15% |
| Q1 2025 | -0.05 | -0.07 | 31.20% | 83.33% | 52.511M | 51.724M | 1.52% | 93.21% |
| Q4 2024 | -0.05 | -0.04 | -20.15% | 82.76% | 50.41M | 51.034M | -1.22% | 159.14% |
| Q3 2024 | -0.03 | -0.06 | 46.72% | 92.68% | 50.025M | 49.579M | 0.90% | 613.22% |
| Q2 2024 | -0.14 | -0.16 | 11.79% | 83.13% | 41.504M | 38.285M | 8.41% | 2,674.33% |
| Q1 2024 | -0.30 | -0.21 | -41.55% | 37.50% | 27.178M | 26.416M | 2.88% | - |
| Q4 2023 | -0.29 | -0.26 | -9.63% | 36.96% | 19.453M | 18.574M | 4.73% | - |
| Q3 2023 | -0.41 | -0.38 | -7.98% | -24.24% | 7.014M | 5.19M | 35.14% | - |
| Q2 2023 | -0.83 | -0.39 | -111.75% | 17.82% | 1.496M | 643.763K | 132.38% | - |
| Q1 2023 | -0.48 | -0.38 | -24.86% | -6.67% | - | - | ||
| Q4 2022 | -0.46 | -0.28 | -66.41% | -21.05% | - | - | ||
| Q3 2022 | -0.33 | -0.26 | -27.71% | 13.16% | - | - | ||
| Q2 2022 | -1.01 | -0.42 | -141.71% | -206.06% | - | - | ||
| Q1 2022 | -0.45 | -0.44 | -2.01% | -95.65% | - | - | ||
| Q4 2021 | -0.38 | -0.42 | 10.01% | -100.00% | - | - | ||
| Q3 2021 | -0.38 | -0.39 | 3.23% | -90.00% | - | - | ||
| Q2 2021 | -0.33 | -0.32 | -2.89% | -120.00% | - | -100.00% | ||
| Q1 2021 | -0.23 | -0.32 | 29.04% | -1,050.00% | - | -100.00% | ||
| Q4 2020 | -0.19 | -0.28 | 31.29% | - | - | - | ||
| Q3 2020 | -0.20 | -0.26 | 21.96% | - | - | - | ||
| Q2 2020 | -0.15 | -0.10 | -52.79% | - | 10.091M | 7.516M | 34.26% | - |
| Q1 2020 | -0.02 | -0.24 | 91.76% | - | 12.243M | 10.353M | 18.26% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
42.28%
Max EPS beat (4)
258.07%
Min EPS beat (4)
-100.00%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
3.03%
Max Revenue beat (4)
8.61%
Min Revenue beat (4)
-1.22%
Analysis
In the last 4 quarters, AVDL has beaten EPS estimates in 2 out of 4 releases
AVDL has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, AVDL has beaten the EPS estimates by 42.3% on average.
In the last 4 quarters, AVDL has beaten the revenue estimates by 3.0% on average.
Avadel Pharmaceuticals PLC / AVDL Earnings FAQ
Can you provide the last earnings date for Avadel Pharmaceuticals PLC?
Avadel Pharmaceuticals PLC (AVDL) last reported earnings on 11/4/2025.
Did Avadel Pharmaceuticals PLC (AVDL) beat earnings estimates last quarter?
Avadel Pharmaceuticals PLC (AVDL) missed EPS estimates and beat revenue estimates in the most recent quarter.
How often does Avadel Pharmaceuticals PLC (AVDL) beat earnings estimates?
In the last 4 quarters, Avadel Pharmaceuticals PLC (AVDL) has beaten EPS estimates in 2 out of 4 releases.